Skip to main content
Filing year 2023

TRANSCELERATE BIOPHARMA INC

West Conshohocken, Pennsylvania·EIN 46-0886344·NTEE H99 · Medical Research·6
Total revenue
$34.2M
Total assets
$48.1M
Total expenses
$0
Reported officers
32
Mission

TRANSCELERATE BIOPHARMA'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT COMMUNITY TO IDENTIFY, PRIORITIZE, DESIGN, AND FACILITATE THE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH-QUALITY DELIVERY OF NEW MEDICINES.MEMBERSHIP IN TRANSCELERATE IS OPEN TO BIOPHARMACEUTICAL COMPANIES WITH RESEARCH & DEVELOPMENT OPERATIONS.

Executive compensation, broken down

Form 990 · Schedule J · 8 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
Former CEO
former officer/director/trustee
$2.5M
Vp Global Communications & Engagement
vice president
$614k
Vp of Portfolio Management
vice president
$575k
Head of Finance & Administration
highest compensated employee
$535k
Exec. Director of Portfolio
highest compensated employee
$519k
Vp of Portfolio Management
vice president
$431k
COO (Eff 07/17/2023)
$322k

Plus 24 unpaid individuals.

Browse compensation in Medical Research

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.